MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/circep.112.973339

Медицинская библиотека · Circulation. Arrhythmia and electrophysiology · 2012

Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience.

Aydin Ali, Hartel Friederike, Schlüter Michael, Butter Christian, Köbe Julia, Seifert Martin, Gosau Nils, Hoffmann Boris, Hoffmann Matthias, Vettorazzi Eik, Wilke Iris, Wegscheider Karl, Reichenspurner Hermann, Eckardt Lars, Steven Daniel, Willems Stephan

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Recently, subcutaneous implantable cardioverter-defibrillator (S-ICD) has become available. The aim of our study was to assess the efficacy of S-ICD in a clinical setting.

METHODS AND

RESULTS

Between June 2010 and July 2011, 40 consecutive patients (42 ± 15 years; body mass index, 27 ± 6 kg/m(2); left ventricular ejection fraction, 47 ± 15%; 28 men) received an S-ICD for primary (n=17) or secondary prevention (n=23 [58%]) at 3 institutions in Germany. Intraoperative defibrillation efficacy testing failed in 1 patient with severely reduced left ventricular ejection fraction; testing was effective in all other patients. All episodes stored in the S-ICD were analyzed for appropriate and inappropriate detection, as well as effective shock delivery to convert ventricular tachyarrhythmia into sinus rhythm. During a median follow-up of 229 (interquartile range, 116-305) days, 4 patients experienced 21 episodes, with correct detection of ventricular tachyarrhythmia and subsequent shock therapy. A total of 28 shocks were delivered in these 4 patients. Mixed logistic regression modeling revealed a shock efficacy of 96.4% (95% CI, 12.8%-100%). The efficacy of first shocks, however, was only 57.9% (95% CI, 35.6%-77.4%). Four episodes were incorrectly classified as ventricular tachyarrhythmia, which led to inappropriate shock delivery in 2 patients.

CONCLUSIONS

Ineffective shock delivery may occur in patients with S-ICD, even after successful intraoperative testing. Multicenter trials are required with close monitoring of safety and efficacy end points to identify patients who may be at risk for shock failure.

Для цитирования: Aydin Ali, Hartel Friederike, Schlüter Michael, Butter Christian, Köbe Julia, Seifert Martin, Gosau Nils, Hoffmann Boris, Hoffmann Matthias, Vettorazzi Eik, Wilke Iris, Wegscheider Karl, Reichenspurner Hermann, Eckardt Lars, Steven Daniel, Willems Stephan. Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience.. Circulation. Arrhythmia and electrophysiology. 2012. DOI: 10.1161/circep.112.973339.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.